- Home
- TAL vs ACLX Comparison
TAL vs ACLX Comparison
Compare TAL & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAL
- ACLX
- Stock Information
- Founded
- TAL 2003
- ACLX 2015
- Country
- TAL China
- ACLX United States
- Employees
- TAL N/A
- ACLX N/A
- Industry
- TAL Other Consumer Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TAL Real Estate
- ACLX Health Care
- Exchange
- TAL Nasdaq
- ACLX Nasdaq
- Market Cap
- TAL 6.0B
- ACLX 5.3B
- IPO Year
- TAL 2010
- ACLX 2022
- Fundamental
- Price
- TAL $9.87
- ACLX $66.48
- Analyst Decision
- TAL Strong Buy
- ACLX Strong Buy
- Analyst Count
- TAL 2
- ACLX 14
- Target Price
- TAL $14.20
- ACLX $107.67
- AVG Volume (30 Days)
- TAL 4.5M
- ACLX 695.1K
- Earning Date
- TAL 01-23-2025
- ACLX 02-26-2025
- Dividend Yield
- TAL N/A
- ACLX N/A
- EPS Growth
- TAL N/A
- ACLX N/A
- EPS
- TAL 0.12
- ACLX N/A
- Revenue
- TAL $1,836,617,000.00
- ACLX $155,818,000.00
- Revenue This Year
- TAL $46.20
- ACLX $12.58
- Revenue Next Year
- TAL $30.66
- ACLX N/A
- P/E Ratio
- TAL $83.65
- ACLX N/A
- Revenue Growth
- TAL 54.46
- ACLX 230.33
- 52 Week Low
- TAL $7.35
- ACLX $47.88
- 52 Week High
- TAL $15.52
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TAL 51.42
- ACLX 32.63
- Support Level
- TAL $9.17
- ACLX $63.63
- Resistance Level
- TAL $9.73
- ACLX $68.24
- Average True Range (ATR)
- TAL 0.37
- ACLX 3.71
- MACD
- TAL 0.03
- ACLX -0.69
- Stochastic Oscillator
- TAL 72.62
- ACLX 16.43
About TAL TAL Education Group
TAL Education Group is a smart learning solutions provider in China. It operates a few business lines including enrichment learning, high school academic tutoring, learning technology, and content solutions, and the like. Among those business lines, TAL focuses on enrichment learning and content solutions.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.